Closed Loop Oxygen Control in Hospitalized COPD Patients

This clinical trial explores a new way to help people with Chronic Obstructive Pulmonary Disease (COPD) who are in the hospital because they have difficulty breathing and low oxygen levels, known as hypoxemia. The study is testing a device called Airvo 3, which has a special OptiO2 mode that automatically adjusts the oxygen levels for the patient. The goal is to see if this device can keep oxygen levels more stable compared to the usual method where healthcare professionals manually adjust the oxygen. This is important because more stable oxygen levels could lead to better outcomes and more comfort for patients with COPD. In this study, participants with COPD will use the Airvo 3 device while staying in the hospital. The device is designed to deliver oxygen through the nose, known as nasal high flow. Researchers will compare how well the device maintains the desired oxygen levels against the standard practice of manually adjusting oxygen. By measuring how consistently the device keeps the patient’s oxygen at the right level, the study aims to determine if this method is more effective. There are no specific risks or benefits mentioned, but a more stable oxygen level could potentially improve the patient's overall condition.